Grant opportunity preview

Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

Offered by National Institutes of Health

HealthcareNationalNovember 5, 2028

Opportunity summary

The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or witho…

Sign in to review full eligibility requirements, application details, matching insights, and verified source links.

Potential award

$400,000

A free Grantclient account is required.